Organisation: Advair

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

business

Vaccine boost for profits at GSK Glaxo - and thousands of Munster jobs

GlaxoSmithKline has beaten second-quarter profit expectations with the help of strong demand for its shingles vaccine, prompting the drugmaker to forecast a smaller fall in profit this year than originally anticipated.

business

GlaxoSmithKline gets profit boost on HIV drugs and sterling

business

GSK to cut US jobs as it targets £1bn in savings

business

GSK plans to rebuild battered company

business

Glaxo shares slide on earnings blow

business

GSK faces probe over bribery claims

Oil fall boosts airline stocks

Hopes of an international compromise on the Syrian crisis fuelled gains on the FTSE 100 Index as oil prices also eased back from recent highs.

Tue, 10 Sep, 2013

Glaxo fined $3bn over US health fraud

Drugs firm GlaxoSmithKline will pay $3bn (€2.4bn) in fines after admitting to the largest healthcare fraud in US history.

Tue, 03 Jul, 2012

Pharma giant to pay $3bn in healthcare fraud case

Pharmaceutical giant GlaxoSmithKline has agreed to plead guilty and pay $3bn (€2.38bn) to resolve criminal and civil allegations that it illegally promoted prescription drugs and failed to report safety data, the US said.

Tue, 03 Jul, 2012

We must diversify, says new Glaxo boss

The new head of GlaxoSmithKline today said the drug giant must change to survive the growing threat of generic competition for its leading products.

Wed, 23 Jul, 2008

Glaxo profits level despite diabetes drug claims

Drug maker GlaxoSmithKline today posted better than expected results, despite sales of its diabetes treatment Avandia falling more than 20% after health scares.

Wed, 25 Jul, 2007

Glaxo meets forecasts as profits rise 16%

GLAXOSMITHKLINE met forecasts with a 16% rise in 2006 profit yesterday and said a dip in growth this year as some old products go off patent would be less than feared.

Fri, 09 Feb, 2007

Glaxo confident after profits rise

A strong performance in the US helped GlaxoSmithKline bank annual profits of £7.8bn (€11.73bn) today as sales of its asthma and diabetes drugs continued to rise.

Thu, 08 Feb, 2007

Glaxo beats hopes with profits rise

Pharmaceuticals giant GlaxoSmithKline today said soaring sales of its asthma drug Advair and diabetes medication Avandia drove profits up 16%.

Wed, 08 Feb, 2006

Drug label change wipes £4bn off Glaxo value

OVER £4 billion was wiped off the value of GlaxoSmithKline (GSK) yesterday after authorities proposed changes to the way its best-selling asthma drug is labelled in the United States.

Tue, 22 Nov, 2005

Drugs giant Glaxo sees pre-tax profits slide 17% to £1.63 billion

DRUGS giant GlaxoSmithKline posted a 17% fall in half-year profits yesterday as it continued to suffer from the impact of generic competition.

Wed, 28 Jul, 2004

GSK posts 17% fall in half-year profits

Pharmaceuticals giant GlaxoSmithKline posted a 17% fall in half-year profits today as it continued to suffer from the impact of generic competition.

Tue, 27 Jul, 2004

GlaxoSmithKline patent revoked

A GlaxoSmithKline patent for its number one product, the asthma medicine Seretide, has been revoked by a British court, a decision that may make it difficult for Europe’s biggest drugmaker to fend off generic challenges in Britain.

Sat, 20 Mar, 2004

Bumper profits posted by pharmaceuticals giant

Pharmaceutical giant GlaxoSmithKline today reported bumper profits of £6.2bn (€10.1bn) for the last year, boosted by sales of its newly launched asthma drug Advair.

Thu, 14 Feb, 2002